Vimarsana
Biggest News Aggregation in the World

Page 29 - Roivant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Roivant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Roivant Sciences Today - Breaking & Trending Today

To Ensure Election Integrity, Ramaswamy Urges Federal Standards - Vimarsana News

To Ensure Election Integrity, Ramaswamy Urges Federal Standards

Ramaswamy, a businessman seeking the GOP presidential nod, discussed the pro-life movement and open borders, as well as election integrity.

JPMorgan Chase & Co. Cuts Roivant Sciences (NASDAQ:ROIV) Price Target to $15.00 - Vimarsana News

JPMorgan Chase & Co. Cuts Roivant Sciences (NASDAQ:ROIV) Price Target to $15.00

Roivant Sciences (NASDAQ:ROIV – Free Report) had its price objective reduced by JPMorgan Chase & Co. from $16.00 to $15.00 in a report issued on Tuesday morning, Benzinga reports. They currently have an overweight rating on the stock. Several other research analysts also recently weighed in on ROIV. Truist Financial reissued a buy rating and […]

Rx Rundown: Legend Biotech, CureVac, Roivant Sciences and more - Vimarsana News

Rx Rundown: Legend Biotech, CureVac, Roivant Sciences and more

Check out this week’s medical marketing news, people on the move and industry chatter.

11 Best Undervalued UK Stocks To Buy Now - Vimarsana News

11 Best Undervalued UK Stocks To Buy Now

In this piece, we will take a look at the 11 best undervalued U.K. stocks to buy now.

Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2023 Earnings Call Transcript - Vimarsana News

Roivant Sciences Ltd. (NASDAQ:ROIV) Q2 2023 Earnings Call Transcript

Operator: Good day, and thank you for standing by. Welcome to the Roivant Q2 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode.